STERIS (STE) senior VP has 337 shares withheld for taxes on vesting

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

STERIS plc senior vice president and general counsel John Adam Zangerle reported a routine share withholding related to restricted stock vesting. On June 1, 2026, 337 ordinary shares were withheld from 1,157 vested restricted shares to cover tax obligations, based on the NYSE closing price that day.

After this tax-withholding disposition, he directly owned 33,332 ordinary shares, including 7,354 restricted shares as of June 1, 2026. The restrictions on these ordinary shares are scheduled to lapse in tranches through June 5, 2028.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Zangerle John Adam

Role Sr. VP, Gen Counsel, and Sec.

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares	337	$0.00	--

Holdings After Transaction: Ordinary Shares — 33,332 shares (Direct, null)

Footnotes (1)

337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026. These 337 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. As of June 1, 2026, 7,354 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028.

Key Figures

Tax-withheld shares: 337 shares Vested restricted shares: 1,157 shares Shares owned after transaction: 33,332 shares +5 more

8 metrics

Tax-withheld shares 337 shares Withheld on June 1, 2026 to cover taxes on vesting

Vested restricted shares 1,157 shares Restricted shares that vested on June 1, 2026

Shares owned after transaction 33,332 shares Direct ordinary share holdings following June 1, 2026 disposition

Restricted shares outstanding 7,354 shares Restricted ordinary shares as of June 1, 2026

Tranche vesting 2026-06-02 846 shares Restricted shares with restrictions lapsing June 2, 2026

Tranche vesting 2026-06-03 1,252 shares Restricted shares with restrictions lapsing June 3, 2026 and June 3, 2027

Tranche vesting 2026-06-04 1,376 shares Restricted shares with restrictions lapsing June 4, 2026 and June 4, 2027

Final tranche vesting 2028-06-05 1,252 shares Restricted shares with restrictions lapsing June 5, 2028

Key Terms

tax-withholding disposition, restricted shares, vested shares, NYSE closing market price, +1 more

5 terms

tax-withholding disposition financial

"337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026. These 337 shares represent the value of the taxes required to be withheld"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

restricted shares financial

"337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vested shares financial

"These vested shares were valued at the NYSE closing market price on June 1, 2026."

NYSE closing market price financial

"These vested shares were valued at the NYSE closing market price on June 1, 2026."

restrictions lapse financial

"The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2026; 1,252 on June 3, 2026;"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 04:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zangerle John Adam

(Last)

(First)

(Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2

D02 R296

(City)

(State)

(Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Sr. VP, Gen Counsel, and Sec.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	06/01/2026		F		337⁽¹⁾	D	$0	33,332⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. 337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026. These 337 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026.

2. As of June 1, 2026, 7,354 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did STERIS (STE) report for John Adam Zangerle?

STERIS reported that John Adam Zangerle had 337 ordinary shares withheld to cover taxes on 1,157 restricted shares that vested on June 1, 2026. This tax-withholding disposition is a routine administrative transaction rather than an open-market stock sale.

How many STERIS (STE) shares were involved in the June 1, 2026 vesting?

On June 1, 2026, 1,157 restricted STERIS ordinary shares vested for John Adam Zangerle. Of these, 337 shares were withheld to satisfy tax obligations, with the withheld amount valued using the NYSE closing market price on that date, as determined by the company.

How many STERIS (STE) shares does John Adam Zangerle hold after the reported transaction?

Following the June 1, 2026 tax-withholding disposition, John Adam Zangerle directly owned 33,332 STERIS ordinary shares. This total includes both unrestricted and restricted shares, reflecting his continuing equity stake in the company after the routine tax-related share withholding.

How many of John Adam Zangerle’s STERIS (STE) shares remain restricted?

As of June 1, 2026, 7,354 of John Adam Zangerle’s 33,332 STERIS ordinary shares were restricted. These restrictions lapse in several scheduled tranches between June 2, 2026 and June 5, 2028, gradually converting restricted shares into fully vested ordinary shares.

What is the schedule for the release of restricted STERIS (STE) shares held by John Adam Zangerle?

Restrictions on 7,354 STERIS restricted shares lapse in tranches: 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3, 2027; 1,376 on June 4, 2027; and 1,252 on June 5, 2028, according to the filing.

Was the STERIS (STE) insider transaction an open-market sale of shares?

No, the filing describes a tax-withholding disposition, not an open-market sale. The 337 shares were withheld from vested restricted shares to cover applicable taxes, with their value based on the NYSE closing market price on June 1, 2026, as determined by STERIS.